Investor · 2 deals
Every published round 62 Capital took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| dorsaVi | Unnamed stage | 6 Oct 2026 | $3m | Participant | Biotech Dispatch, Dealroom | |
| Critical Resources | Unnamed stage | 11 Sep 2026 | $1.6m | Lead | The Age Business, SMH Business |
Companies 62 Capital has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| dorsaVi | 6 Oct 2026 | 1 | 0 | |
| Critical Resources | 11 Sep 2026 | 1 | 1 |
Fund closes reported for 62 Capital, as distinct from the investments it has made.
Companies 62 Capital has backed that another company then bought. An exit for the holding, not a deal 62 Capital did.
Stories naming 62 Capital. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASX-listed Melbourne sensor maker dorsaVi has raised US$1.94 million in a post-IPO placement backed by 62 Capital, to expand its movement-data library and advance neuromorphic and RRAM chip development.
Also Biotech Dispatch
Roundup of 35 ASX capital raisings seeking a combined $687.5m in late August and early September, led by mining deals; Canaccord Genuity topped the broker table and three IPOs floated.
Roundup tallies 35 ASX equity fundraises seeking $687.5 million, mostly miners; Canaccord Genuity led broker mandates with nine deals, while FireFly Metals' $190 million package was the period's largest.
Also The Age Business